NASDAQ · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
AirSculpt Technologies, Inc. AIRS
7 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$151.8M
▼ 15.8% vs FY2024
EPS · FY25
$-0.19
Dividend / sh · FY25
—
Payout · FY25
-0%
ROE · FY25
-14.1%
Net margin · FY25
-7.7%
Dividend coverage
-0.6×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 151.8M
Revenue, FY2025 · full 7-year series below
Revenue
Net income
The company lost 8 cents on every revenue dollar this year.
Per share
USD -0.19
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-14.1%
Return on equity, FY2025
ROE
Operating margin-7.6%
Net margin-7.7%
Return on assets-5.8%
Each USD of equity lost 14 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit-0.0%
Consecutive raises—
Growth
+19.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−3.5%
+19.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.06B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 187.3M
total assets, end of FY2025
Total assetsUSD 187.3M
EquityUSD 87.7M
CashUSD 8.4M
Gross debtUSD 56.0M
Net debtUSD 47.6M
Current ratio0.55×
Net debt stands at 54% of equity.
History
7 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue $B
0.2
0.2
0.2
0.2
0.1
0.1
0.0
Operating income $B
−0.0
−0.0
0.0
−0.0
0.0
0.0
0.0
EBITDA $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
EPS, diluted $
−0.19
−0.14
−0.08
−0.26
0.01
·
·
Dividend / sh $
·
·
·
0.41
·
·
·
Payout %
−0
−3
−9
−158
0
0
·
ROE %
−14.1
−10.0
−5.5
−19.0
12.6
·
·
Shares out B
0.06
0.06
0.06
0.06
0.06
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
17 of 17
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed